Dushyant Mishra

Founder and CEO RapidClaims

Last Reviewed: September 19, 2026

Executive Summary

Dushyant Mishra is founder and chief executive of RapidClaims, a New York company attacking one of the least glamorous and most expensive problems in American healthcare: the coding and claims work that stands between a clinician doing something and a provider being paid for it. He founded it in 2023 with Jot Sarup Singh and Abhinay Vyas, and the company’s products use large language models to code charts autonomously, close documentation gaps and catch the payer-side errors that produce denials. The idea came out of his time at Abbott, where he saw hospital finances strained by administrative failure rather than clinical failure. RapidClaims has raised $11 million across a seed round and an Accel-led Series A, and sells across federally qualified health centres, physician groups and the outpatient arms of large health systems.

Career Highlights

• Co-founded RapidClaims in 2023 with Jot Sarup Singh, the company’s chief product and technology officer, and Abhinay Vyas, its chief data officer, and has led it as chief executive since.
• Raised an $8 million Series A led by Accel with Together Fund participating, announced in April 2025, on top of a previously undisclosed $3 million seed round, for $11 million in total disclosed funding.
• Attracted angel investment from operators inside the problem domain, including Oscar Benavidez of Massachusetts General Hospital, Matthew Zubiller of e4health, Infinitus chief executive Ankit Jain and Sachin Jain.
• Shipped RapidCode, an autonomous medical coding product, alongside tools for clinical documentation improvement and claim scrubbing; the company reports being live in more than 25 specialties with high autonomous accuracy in over 20 of them, and integrated with more than 15 electronic health record systems.
• Reported sixfold growth in the four months preceding the April 2025 round, and took the company to HIMSS 2026 as an exhibitor.

Professional Journey

Mishra’s route to healthcare billing ran through pharmaceutical commercial operations. At Abbott he worked on strategic projects and commercial operations across South Asia, a vantage point from which the financial condition of hospitals is unusually visible — and where, by his account, he came to see how much provider revenue was lost not to clinical or market failure but to coding errors, documentation gaps and denied claims.

He then spent a period on the investing side as an early-stage investor with Together Fund, the SaaS-focused venture firm, working with startups building for global markets, and advised Fathom, a Y Combinator-backed company working on autonomous medical coding. That combination — domain exposure to provider economics, plus a close view of how software companies are built and funded — is the background he brought to founding his own company.

RapidClaims was founded in 2023 and launched publicly in February 2024 with seed backing orchestrated by Together Fund. Mishra’s framing at launch was that automation alone was not the point: the goal was accuracy in coding, because coding accuracy is what determines whether a claim is denied. The product line grew from autonomous coding into clinical documentation improvement, claim scrubbing, risk-adjusted coding for value-based care and recovery work.

By April 2025 the company had grown sixfold in four months and raised an $8 million Series A led by Accel, with Together Fund following on and a set of hospital and health-technology operators investing personally. Mishra’s stated differentiator was breadth rather than depth: a multi-specialty product live across more than 25 specialties, against competitors built for a single specialty. The company’s declared next move was to expand from the mid-revenue cycle into claim adjudication and the end-revenue cycle. RapidClaims remained active into 2026, exhibiting at HIMSS.

Education

No education was established for this profile. The degree previously recorded traced only to business-data aggregators, and neither RapidClaims’ own materials nor any funding announcement or interview names a university. The removed values are recorded in the internal verification notes so they can be restored if a primary source is found.